Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Aug 15;84(5):488-496.
doi: 10.1097/QAI.0000000000002369.

Social Impacts Among Participants in HIV Vaccine Trial Network (HVTN) Preventive HIV Vaccine Trials

Michele P Andrasik  1   2 , Fredericka Albertina Sesay  2 , Abby Isaacs  1 , Linda Oseso  1 , Mary Allen  3
Affiliations

Social Impacts Among Participants in HIV Vaccine Trial Network (HVTN) Preventive HIV Vaccine Trials

Michele P Andrasik et al. J Acquir Immune Defic Syndr. .

Abstract

Background: Given the persistent stigma and discrimination against HIV worldwide, preventive HIV vaccine trials face unique challenges. Negative social impacts (NSIs)-problems that HIV vaccine trial participants face in many different spheres of their lives related to trial participation-have received a great deal of attention. Beneficial social impacts (BSIs)-perceived benefits experienced by a participant and resulting from their trial participation-are a critical component of participants' experiences, yet they have received little attention.

Setting: All HIV Vaccine Trials Network trial participants for whom social impact data were available-8347 participants in 13 countries who enrolled in 48 phase 1, 2a, and 2b trials.

Methods: A cross-protocol analysis to assess self-reported BSIs and NSIs related to participating in a preventive HIV vaccine trial. Data were obtained from 48 completed HIV Vaccine Trials Network vaccine trials from December 2000 to September 2017.

Results: Overall, 6572 participants (81%) reported at least one BSI, and 686 participants (8%) reported 819 NSI events. Altruism/feeling good helping others was the BSI most often endorsed by study participants (43%), followed by receiving risk-reduction counseling (30%). Most NSI events (81%) were reported by US/Swiss participants, and most (79%) trial-related NSIs were negative reactions from friends, family, and partners. Of the NSIs reported, 7% were considered to have a major impact on the participant's quality of life.

Conclusion: Our results underscore the relatively common experiences of BSIs among preventive HIV vaccine trial participants and mirror the results of other studies that find infrequent reports of NSIs.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Percentage of Participants Reporting a Social Benefit or a Negative Social Impact by Participant Characteristics
See this image and copyright information in PMC

References

    1. UNAIDS. Global AIDS Update: Communities At The Centre 2019. Available at: https://www.unaids.org/sites/default/files/media_asset/2019-global-AIDS-.... Accessed August 10, 2019.
    1. Newman PA, Duan N, Kakinami L, et al. What can HIV vaccine trials teach us about future HIV vaccine dissemination? Vaccine. 2008;26(20):2528–2536. - PMC - PubMed
    1. Belshe RB, Clements ML, Keefer MC, et al. Interpreting HIV serodiagnostic test results in the 1990s: Social risks of HIV vaccine studies in uninfected volunteers. Ann Intern Med. 1994;121(8):584–589. - PubMed
    1. Grady C The search for an AIDS vaccine: Ethical issues in the development and testing of a preventive HIV vaccine. Indiana University Press; 1995.
    1. Temoshok LR. Behavioral research contributions to planning and conducting HIV vaccine efficacy studies. AIDS Res Hum Retroviruses. 1994;10 Suppl 2:S277–80. - PubMed

Publication types